home *** CD-ROM | disk | FTP | other *** search
/ Cancer - Principles & Practice of Oncology / Oncology.iso / PPO / CHAP45 / T5_6.GIF < prev    next >
Graphics Interchange Format  |  1999-06-07  |  144.1 KB  |  746x303  |  8-bit (240 colors)
   ocr: TABLE 45.0-6. Supportive Therapy With Hematopoietic Growth Factors in Myelodysplastic Syndromes Decrease 17 Increase mn Increase 272 Leukemic Growth RBC Transfusions Granulocytes Platelets Transjormation Source Factor* Patiends (%)t (%)t (%)t (%)t Rose et al.55 Epo 100 18 NG NG 5 Willemze et al.98 GM-CSF 82 0 66 2 2 Negrin et al.58 G-CSF 18 18 891 9 27 Negrin et al.70 G-CSF/Epo 28 27 100 0 4 Ganser et: al.72 IL-3 9 0 11 11 0 Nand et al.74 IL-3/GM-CSF 9 0 78 33 (transient) 0 Gordon et al.75 IL-6 22 0 0 36 4 NG, not given. Abbreviations arc defined in the text. +The percentage of patients treate ...